| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 47.57B | 47.05B | 37.07B | 31.28B | 29.01B | 27.01B |
| Gross Profit | 17.94B | 17.72B | 14.34B | 12.04B | 10.84B | 10.64B |
| EBITDA | 3.00B | 3.23B | 3.15B | 2.38B | 2.09B | 1.29B |
| Net Income | 1.81B | 2.06B | 1.97B | 1.43B | 1.56B | 199.00M |
Balance Sheet | ||||||
| Total Assets | 27.27B | 26.22B | 24.22B | 19.36B | 18.86B | 16.90B |
| Cash, Cash Equivalents and Short-Term Investments | 8.25B | 9.62B | 10.46B | 10.37B | 10.36B | 8.80B |
| Total Debt | 1.92B | 1.96B | 2.47B | 104.00M | 506.00M | 828.00M |
| Total Liabilities | 9.63B | 9.00B | 9.29B | 5.09B | 5.94B | 5.74B |
| Stockholders Equity | 16.43B | 16.05B | 13.98B | 13.11B | 11.73B | 10.07B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 697.00M | 2.26B | 461.00M | 2.12B | 1.26B |
| Operating Cash Flow | 0.00 | 1.22B | 2.60B | 649.00M | 2.31B | 1.47B |
| Investing Cash Flow | 0.00 | -1.43B | -1.33B | -206.00M | -188.00M | -126.00M |
| Financing Cash Flow | 0.00 | -589.00M | -1.07B | -507.00M | -377.00M | 372.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥27.52B | 12.43 | ― | 3.83% | 7.88% | -5.92% | |
69 Neutral | ¥100.06B | 17.12 | ― | 2.27% | 22.22% | 26.29% | |
66 Neutral | ¥21.54B | 19.21 | ― | 3.57% | -2.73% | -51.48% | |
64 Neutral | ¥41.67B | 22.93 | ― | 0.26% | 15.30% | -15.97% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
45 Neutral | ¥7.62B | -1.92 | ― | ― | -4.54% | -261.55% |